OMT-28
OMT-28 is a synthetic analog of omega-3 epoxyeicosatrienoic acids developed for atrial fibrillation.[1][2]
References[edit]
- ^ Berlin, Sarah; Goette, Andreas; Summo, Luciana; Lossie, Janine; Gebauer, Alexander; Al-Saady, Naab; Calo, Leonardo; Naccarelli, Gerald; Schunck, Wolf-Hagen; Fischer, Robert; Camm, A.John; Dobrev, Dobromir (August 2020). "Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study". IJC Heart & Vasculature. 29: 100573. doi:10.1016/j.ijcha.2020.100573. PMC 7356118. PMID 32685659.
- ^ Dan, Gheorghe-Andrei (6 August 2020). "Non-traditional antiarrhythmic drugs as upstream and downstream dam for atrial fibrillation burden". International Journal of Cardiology. Heart & Vasculature. 29: 100610. doi:10.1016/j.ijcha.2020.100610. ISSN 2352-9067. PMC 7452524. PMID 32885033.